COVID-19 infections and related deaths continue to rise at nursing homes in Wisconsin, the latest numbers from AARP show. Over the four weeks ending Sept. 19, the rate of COVID-19 deaths more than doubled from 0.05 to 0.11 per 100 residents, according to the organization’s nursing...
Researchers at UW-Madison have developed a multi-layered coating technique for probiotics that could improve how diseases are treated with these medications. Probiotics consist of helpful bacteria that can be used to treat intestinal problems such as inflammatory bowel disease. They have been shown to improve the...
Immuto Scientific, Inc., a biotechnology company spun out of the University of Wisconsin-Madison, announced today that it has successfully closed on a $2.3 million seed-funding round. The funding will enable the Madison-based company to scale-up equipment and staffing to provide commercial analytical research services to already-identified...
MADISON – With funding from a National Institutes of Health 2021 High Risk, High Reward New Innovator Award, Shuang (George) Zhao, University of Wisconsin–Madison professor of human oncology, hopes to better understand why and how some cancers become resistant to treatment. Cancer is a leading cause...
-- UW-Madison has distributed $7.7 million in pandemic assistance funding to 6,500 “high-need” students this week. The funds are being issued as part of a rollout of $28.6 million in federal emergency aid going to UW-Madison students this year, to offset the financial impacts of the...
A recent study of around 300 COVID-19 patients in Wisconsin found that vaccinated people had similar levels of viral particles in their nasal passages as those who were unvaccinated. The study from UW-Madison, Exact Sciences and Public Health Madison and Dane County suggests that those...
-- Researchers at UW-Madison are creating a data tool to improve COVID-19 vaccine access, with a goal of surmounting economic and social health disparities. A release from the university shows that federal officials have relied on mathematical modeling to make decisions on vaccine allocation. But researchers...
A team of researchers led by the University of Wisconsin School of Medicine and Public Health was awarded a four-year, $4 million grant by the National Football League to study the prevention and treatment of hamstring injuries for elite football players. Hamstring injuries are the...
-- A Madison-based startup called Archeus Technologies is gearing up to apply for FDA approval to begin human trials on a new targeting agent used in cancer therapy. This cancer-targeting agent is being used by researchers at UW-Madison and the University of Pittsburgh School of Medicine,...
More doesn’t necessarily mean better — including in cancer treatment. University of Wisconsin–Madison and University of Pittsburgh School of Medicine scientists report today in the journal Science Translational Medicine that combining targeted radiopharmaceutical therapy with immunotherapy significantly boosts eradication of metastatic cancer in mice, even when...